eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel
support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

close this panel
←Back
‹‹ Go Back

Bingzhi Zhang

Sanofi



‹‹ Go Back

Hui Quan

Sanofi



‹‹ Go Back

Lin Wang

Sanofi



‹‹ Go Back

Lynn Wei

Sanofi



73 – Randomization and Covariate Adjustment

The Risk of Imbalance in Treatment Assignments in Stratified Blocked Randomized Clinical Trials

Sponsor: Biopharmaceutical Section
Keywords: Stratification, blocking, imblance, randomized clinical trials

Bingzhi Zhang

Sanofi

Hui Quan

Sanofi

Lin Wang

Sanofi

Lynn Wei

Sanofi

In clinical trials, the stratification and blocking method is frequently used to achieve balance in prognostic factors across treatment groups. However, such randomization strategy has a disadvantage that may lead to overall imbalance in sample size across treatment groups when the number of strata is large. To measure the risk of such imbalance, Hallstrom and Davis (1988) provided the variance of the sample size difference between two treatment groups. However, the distribution assumptions made in their method has limited its validity and applicability. This limitation was confirmed by the simulation studies conducted by Kundt and Glass (2012). Kundt and Glass then proposed utilizing simulation to assess the likelihood of imbalance inclinical trials where Hallstrom and Davis' assumptions are no longer valid. In this paper, we proposed a new method deriving the exact probability density function (pdf) of the sample size difference between any two treatment groups in any multiple-arm and stratified blocked randomized clinical trials. It will help the clinical trial designers choose an appropriate stratification strategy at the planning stage to avoid serious imbalanced trials at the end.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2014 CadmiumCD